Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1623-1628
Published online before print May 19, 2005, doi: 10.1161/01.ATV.0000170827.16296.6e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
25/8/1623    most recent
01.ATV.0000170827.16296.6ev1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McNally, J. S.
Right arrow Articles by Harrison, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McNally, J. S.
Right arrow Articles by Harrison, D. G.
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1623.)
© 2005 American Heart Association, Inc.


Vascular Biology

Regulation of Xanthine Oxidoreductase Protein Expression by Hydrogen Peroxide and Calcium

J. Scott McNally; Archana Saxena; Hua Cai; Sergey Dikalov; David G. Harrison

From the Division of Cardiology (J.S.M., A.S., S.D., D.G.H.), Molecular and Systems Pharmacology Program (J.S.M., D.G.H.), Emory University, Atlanta, Ga; the Atlanta Veterans Hospital Medical Center, Atlanta, Ga; and the Department of Medicine (H.C.), University of Chicago, Ill.

Correspondence to David G. Harrison, Division of Cardiology, Emory University, 101 Woodruff Cir, WMB 319, Atlanta, GA 30322. E-mail dharr02{at}emory.edu

Objective— We have previously demonstrated that endothelial xanthine oxidase (XO) levels are dependent on the NADPH oxidase. We postulated that H2O2 may modulate the irreversible conversion of xanthine dehydrogenase (XDH) to XO and sought to examine mechanisms involved.

Methods and Results— H2O2 (100 µmol/L) decreased bovine aortic endothelial cell (BAEC) XDH protein expression, and metabolic labeling studies indicated that H2O2 stimulated conversion of XDH to XO. The decline in XDH was mimicked by the reactive oxygen species (ROS) generating compounds SIN-1 and Menadione, as well as by stimulating BAECs with angiotensin II (200 nmol/L). BAPTA-AM prevented the decline in XDH by H2O2, indicating that it was calcium-dependent. In keeping with calcium acting downstream of H2O2, the calcium ionophore A23187 (1 µmol/L) caused XDH-to-XO conversion, and this was not prevented by the antioxidants. In addition, XDH-to-XO conversion was blocked by 2-APB and NO donors and induced by thapsigargin and M-3M3FBS, implicating phospholipase C and endoplasmic reticulum calcium stores in this process.

Conclusions— Endothelial XO and XDH expression are strongly dependent on H2O2 and calcium. Stimulation of XDH conversion to XO may represent a feed-forward mechanism whereby H2O2 can stimulate further production of ROS.

In this study we found that H2O2-dependent calcium release from the ER caused conversion of XDH to XO, and that this was prevented by nitric oxide. This may represent a feed-forward mechanism in many disease processes whereby H2O2 can stimulate further ROS production through XDH-to-XO conversion.


Key Words: calcium • hydrogen peroxide • reactive oxygen species • vascular endothelium • xanthine oxidoreductase




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
S. J. Wilson, C. C. Cavanagh, A. M. Lesher, A. J. Frey, S. E. Russell, and E. M. Smyth
Activation-dependent stabilization of the human thromboxane receptor: role of reactive oxygen species
J. Lipid Res., June 1, 2009; 50(6): 1047 - 1056.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J. P. Forman, H. Choi, and G. C. Curhan
Fructose and Vitamin C Intake Do Not Influence Risk for Developing Hypertension
J. Am. Soc. Nephrol., April 1, 2009; 20(4): 863 - 871.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Szasz, J. M. Thompson, and S. W. Watts
A comparison of reactive oxygen species metabolism in the rat aorta and vena cava: focus on xanthine oxidase
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1341 - H1350.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G.-X. Zhang, X.-M. Lu, S. Kimura, and A. Nishiyama
Role of mitochondria in angiotensin II-induced reactive oxygen species and mitogen-activated protein kinase activation
Cardiovasc Res, November 1, 2007; 76(2): 204 - 212.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. A. Sorrentino, F. H. Bahlmann, C. Besler, M. Muller, S. Schulz, N. Kirchhoff, C. Doerries, T. Horvath, A. Limbourg, F. Limbourg, et al.
Oxidant Stress Impairs In Vivo Reendothelialization Capacity of Endothelial Progenitor Cells From Patients With Type 2 Diabetes Mellitus: Restoration by the Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Rosiglitazone
Circulation, July 10, 2007; 116(2): 163 - 173.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. O. Lerman and A. Lerman
All Oxidase Roads Lead to Angiotensin, Too
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 703 - 704.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U. Landmesser, S. Spiekermann, C. Preuss, S. Sorrentino, D. Fischer, C. Manes, M. Mueller, and H. Drexler
Angiotensin II Induces Endothelial Xanthine Oxidase Activation: Role for Endothelial Dysfunction in Patients With Coronary Disease
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 943 - 948.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Doerries, K. Grote, D. Hilfiker-Kleiner, M. Luchtefeld, A. Schaefer, S. M. Holland, S. Sorrentino, C. Manes, B. Schieffer, H. Drexler, et al.
Critical Role of the NAD(P)H Oxidase Subunit p47phox for Left Ventricular Remodeling/Dysfunction and Survival After Myocardial Infarction
Circ. Res., March 30, 2007; 100(6): 894 - 903.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, A. Nivorozhkin, and C. Szabo
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Pharmacol. Rev., March 1, 2006; 58(1): 87 - 114.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. J. Guzik, J. Sadowski, B. Guzik, A. Jopek, B. Kapelak, P. Przybylowski, K. Wierzbicki, R. Korbut, D. G. Harrison, and K. M. Channon
Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease
Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 333 - 339.
[Abstract] [Full Text] [PDF]